HIV dynamics and integrase inhibitors.

about

Modelling HIV-1 2-LTR dynamics following raltegravir intensification.Experiment Design for Early Molecular Events in HIV Infection.

P2860

Q36904249-3E400C14-2DB0-4BAB-ADE6-4AB834D57FA6 Q49674917-B1289811-8A6D-4435-BABB-A68209C537C0

P2860

HIV dynamics and integrase inhibitors.

Item

http://www.wikidata.org/entity/Q44255172

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

HIV dynamics and integrase inhibitors.

@en

HIV dynamics and integrase inhibitors.

@nl

type

Item

label

HIV dynamics and integrase inhibitors.

@en

HIV dynamics and integrase inhibitors.

@nl

prefLabel

HIV dynamics and integrase inhibitors.

@en

HIV dynamics and integrase inhibitors.

@nl

P1476

HIV dynamics and integrase inhibitors.

@en

P2093

John M Murray

http://www.w3.org/2001/XMLSchema#string

P2860

Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study

Raltegravir with optimized background therapy for resistant HIV-1 infection

Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

Viral dynamics in human immunodeficiency virus type 1 infection

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

Decay characteristics of HIV-1-infected compartments during combination therapy

HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir.

P304

157-164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/095632020901900403

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24305300

http://www.w3.org/2001/XMLSchema#string

P698

19374143

http://www.w3.org/2001/XMLSchema#string

HIV dynamics and integrase inhibitors.

about

P2860

P2860

HIV dynamics and integrase inhibitors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698